Operating Income (Loss) of Nu-Med Plus, Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Nu-Med Plus, Inc. annual and quarterly Operating Income (Loss) in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • Nu-Med Plus, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2024 was $17,417, a 15% decline year-over-year.
  • Nu-Med Plus, Inc. annual Operating Income (Loss) for 2024 was $63,331, a 47% increase from 2023.
  • Nu-Med Plus, Inc. annual Operating Income (Loss) for 2023 was $120,526, a 34% increase from 2022.
  • Nu-Med Plus, Inc. annual Operating Income (Loss) for 2022 was $182,167, a 78% increase from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)

Nu-Med Plus, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $63,331 +$57,195 +47% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $120,526 +$61,641 +34% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $182,167 +$657,278 +78% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $839,445 +$1,155,232 +58% 01 Jan 2021 31 Dec 2021 10-K/A 03 Apr 2023 2022 FY
2020 $1,994,677 -$975,247 -96% 01 Jan 2020 31 Dec 2020 10-K/A 11 Apr 2022 2021 FY
2019 $1,019,430 +$149,881 +13% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $1,169,311 -$702,792 -151% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $466,519 +$758,080 +62% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 $1,224,599 -$278,121 -29% 01 Jan 2016 31 Dec 2016 10-K 03 Apr 2018 2017 FY
2015 $946,478 +$199,643 +17% 01 Jan 2015 31 Dec 2015 10-K 19 Apr 2017 2016 FY
2014 $1,146,121 -$912,485 -391% 01 Jan 2014 31 Dec 2014 10-K 13 Apr 2016 2015 FY
2013 $233,636 +$24,591 +9.5% 01 Jan 2013 31 Dec 2013 10-K 23 Mar 2015 2014 FY
2012 $258,227 01 Jan 2012 31 Dec 2012 10-K 21 Feb 2014 2013 FY

Nu-Med Plus, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $17,417 -$2,271 -15% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q1 2024 $114,134 $20,579 +$6,392 +24% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $120,526 $55,336 -$48,942 -765% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $71,584 $15,146 +$42,904 +74% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $114,488 $23,073 +$34,997 +60% 01 Apr 2023 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $149,485 $26,971 +$32,682 +55% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $182,167 $6,394 +$105,947 +94% 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $288,114 $58,050 +$60,316 +51% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 $348,430 $58,070 +$193,920 +77% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $542,350 $59,653 +$297,095 +83% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $839,445 $112,341 +$378,819 +77% 01 Oct 2021 31 Dec 2021 10-K/A 03 Apr 2023 2022 FY
Q3 2021 $1,218,264 $118,366 +$331,392 +74% 01 Jul 2021 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $1,549,656 $251,990 +$652,456 +72% 01 Apr 2021 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $2,202,112 $356,748 -$207,435 -139% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $1,994,677 $491,160 -$285,456 -139% 01 Oct 2020 31 Dec 2020 10-K/A 11 Apr 2022 2021 FY
Q3 2020 $1,709,221 $449,758 -$303,545 -208% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $1,405,676 $904,446 -$660,661 -271% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $745,015 $149,313 +$274,415 +65% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $1,019,430 $205,704 +$130,262 +39% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $1,149,692 $146,213 +$375,856 +72% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $1,525,548 $243,785 -$75,072 -44% 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2020 2020 Q2
Q1 2019 $1,450,476 $423,728 -$281,165 -197% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q4 2018 $1,169,311 $335,966 -$188,225 -127% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $981,086 $522,069 -$384,320 -279% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $596,766 $168,713 -$57,410 -52% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $539,356 $142,563 -$72,837 -104% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $466,519 $147,741 +$137,419 +48% 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $603,938 $137,749 +$558,066 +80% 01 Jul 2017 30 Sep 2017 10-Q 19 Nov 2018 2018 Q3
Q2 2017 $1,162,004 $111,303 +$66,660 +37% 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 $1,228,664 $69,726 -$4,065 -6.2% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q1
Q4 2016 $1,224,599 $285,160 -$150,015 -111% 01 Oct 2016 31 Dec 2016 10-K 03 Apr 2018 2017 FY
Q3 2016 $1,074,584 $695,815 -$392,447 -129% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $682,137 $177,963 +$211,328 +54% 01 Apr 2016 30 Jun 2016 10-Q 18 Aug 2017 2017 Q2
Q1 2016 $893,465 $65,661 +$53,013 +45% 01 Jan 2016 31 Mar 2016 10-Q 17 May 2017 2017 Q1
Q4 2015 $946,478 $135,145 +$394,749 +74% 01 Oct 2015 31 Dec 2015 10-K 19 Apr 2017 2016 FY
Q3 2015 $1,341,227 $303,368 -$64,431 -27% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $1,276,796 $389,291 -$190,989 -96% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $1,085,807 $118,674 +$60,314 +34% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q4 2014 $1,146,121 $529,894 -$498,425 -1584% 01 Oct 2014 31 Dec 2014 10-K 13 Apr 2016 2015 FY
Q3 2014 $647,696 $238,937 -$151,193 -172% 01 Jul 2014 30 Sep 2014 10-Q 23 Nov 2015 2015 Q3
Q2 2014 $496,503 $198,302 -$164,395 -485% 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2
Q1 2014 $332,108 $178,988 -$98,472 -122% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q4 2013 $233,636 $31,469 +$50,248 +61% 01 Oct 2013 31 Dec 2013 10-K 23 Mar 2015 2014 FY
Q3 2013 $283,884 $87,744 +$22,974 +21% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 $306,858 $33,907 +$12,343 +27% 01 Apr 2013 30 Jun 2013 10-Q 11 Aug 2014 2014 Q2
Q1 2013 $319,201 $80,516 -$60,974 -312% 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014 2014 Q1
Q4 2012 $258,227 $81,717 -$78,076 -2144% 01 Oct 2012 31 Dec 2012 10-K 21 Feb 2014 2013 FY
Q3 2012 $180,151 $110,718 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2013 Q3
Q2 2012 $46,250 01 Apr 2012 30 Jun 2012 10-Q 13 Aug 2013 2013 Q2
Q1 2012 $19,542 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q4 2011 $3,641 19 Oct 2011 31 Dec 2011 10-K 28 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.